| Management target | Revenue 20.0% FY28 |
|---|
| Revenue growth | 5% YoY in Q1FY27; 20%+ CAGR target. |
|---|---|
| Margins | EBITDA margin expected to expand to 25%+. |
| Demand visibility | Strong; current capacity utilization at 96%. |
| Management confidence | High; aiming for structural margin improvement. |
Growth
FY26 revenue grew to INR 288 Cr; Q1FY27 revenue INR 69 Cr. EBITDA CAGR of 10% (FY21-26).
Outlook
Guided Revenue CAGR 20%+ and EBITDA margin 25%+ for next two years. Commissioning SteriPort/SVP expansion in FY27.
Risks
Exposure to inflationary cost increases and overheads; high historical debt-to-equity ratio (now improving).
Last quarter's promises, checked
Delivered
- SteriPort capacity expansion project → Commissioned by June 2026 (= BEAT)
- Debt-to-equity ratio improvement → Reduced from 3x to ~1x (= BEAT)
- 10.8 MW captive solar project → Commissioning by late May 2026 (= BEAT)
Partly delivered
- Q1FY27 Revenue Growth → Delivered 5% YoY vs 20%+ CAGR target (= PARTIAL)
Investor Presentation filed with NSE, NSE: AMANTA. Summary written with AI assistance from the document.
Amanta Healthcare Ltd: key numbers
- Share price
- ₹186.00
- Market cap
- ₹722.2 Cr
- Revenue (annual)
- ₹287.7 Cr
- Net profit (annual)
- ₹14.88 Cr
- P/E (TTM)
- 49.2×Sector 50.4×
- Promoter holding
- 63.80%+0.08% QoQ
- FII holding
- 0.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amanta Healthcare Ltd
All →Amanta Healthcare Management Change
Amanta Healthcare Limited appointed Nimesh P Patel as Non-Executive Non-Independent Director. The company also appointed M/s. Kashyap R. Mehta & Partners as the Secretarial Auditor.
Amanta Healthcare Annual General Meeting
Amanta Healthcare held its 31st Annual General Meeting on September 16, 2026, transacting ordinary and special business items via video conferencing.
Amanta Healthcare Production Started
Amanta Healthcare has commenced production at its new SteriPort facility at the Kheda campus. This brownfield expansion aims to improve operational efficiency and EBITDA margins.
Amanta Healthcare Earnings Call Transcript: Key Takeaways
Amanta Healthcare delivers solid FY26 results with significant profit growth, transitioning toward high-margin specialized products like Steriport and ophthalmic solutions.
Amanta Healthcare Q1 FY27 Results: Net Profit ₹3.3 Cr, Down 5.7% YoY
Amanta Healthcare Ltd reported revenue from operations of ₹68.8 Cr (+5.4% YoY) and net profit of ₹3.3 Cr (-5.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹3.3 Cr · -5.7% YoY
Amanta Healthcare Earnings Call: Key Takeaways
Amanta reported FY26 revenue of ₹288cr with 22% EBITDA margins. Strategy focuses on high-margin SteriPort capacity expansion and renewable energy cost savings.